My travel plans have
changed and I will be able to attend…Looking forward to seeing you all!
Kurt
From:
epf-dev-bounces@xxxxxxxxxxx [mailto:epf-dev-bounces@xxxxxxxxxxx] On Behalf Of Steve Adolph
Sent: Friday, October 19, 2007
1:51 AM
To: 'Eclipse
Process Framework Project Developers List'
Cc: 'Ryan Martens'; 'Dean
Leffingwell'
Subject: [epf-dev] EPF Face to
Face Dec 6th and 7th at Rally Development inBoulder Colorado
Hello Everyone:
It is official: We will be having our next EPF Face to
Face meeting December 6th and 7th at Rally Development’s
offices in Boulder Colorado. The agenda for this meeting
includes the following topics:
a.
Discuss and commit to a release plan
at the F2F.
b.
Discuss the “practice library”
at the F2F. (Per to lead)
c.
Working session on OpenUP enablement
at the F2F. (Steve to lead)
d.
Discuss how to growing the EPF
community. (Per to lead)
e.
Discuss translation effort and
process for translation (how do we validate/approve). (Ricardo to lead)
f.
OpenUP improvements (Nate to lead)
g.
EPFWiki training (Onno)
Can you please indicate at your earliest convenience
if you will attend this F2F.
Best regards,
Steve Adolph
Collaborate to Innovate!
Register today for Telelogic's annual User Group Conference November 19-21 in
South Wales
Learn more at www.telelogic.com/campaigns/2007/ugc/uk/index.cfm
--------------------------------------------------------------------------------
Telelogic Lifecycle
Solutions:
Helping You Define,
Design & Deliver Advanced Systems & Software
Learn More at www.telelogic.com
Ben Williams
Director of Product Management, Lifecycle Solutions
Telelogic UK Ltd
Northbrook House, Oxford Science Park
OX4 4GA, Oxford
United Kingdom
Phone: +44 020 7193 7067
Fax: +44 (1865) 784 286
Mobile phone:+44 (7710) 637 067
Ben.Williams@xxxxxxxxxxxxx
http://www.telelogic.com
Telelogic - Requirements-Driven Innovation!
-------------------------------------------------------------
The information contained in this e-mail,
including any attachment or enclosure, is intended only for the person or
entity to which it is addressed and may contain confidential material. Any
unauthorized use, review, retransmissions, dissemination, copying or other use
of this information by persons or entities other than the intended recipient is
prohibited.